Menu
GeneBe

TRIB3

tribbles pseudokinase 3

Basic information

Region (hg38): 20:362834-397559

Previous symbols: [ "C20orf97" ]

Links

ENSG00000101255NCBI:57761OMIM:607898HGNC:16228Uniprot:Q96RU7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • cardiomyopathy (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TRIB3 gene.

  • Inborn genetic diseases (24 variants)
  • not provided (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIB3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
22
clinvar
2
clinvar
24
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 22 2 2

Variants in TRIB3

This is a list of pathogenic ClinVar variants found in the TRIB3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-388057-A-G not specified Uncertain significance (Jan 03, 2024)3182177
20-388066-T-C not specified Uncertain significance (Sep 19, 2022)2312645
20-388091-C-T Benign (Jul 30, 2018)710947
20-388096-G-A not specified Likely benign (Nov 17, 2023)3182186
20-388111-G-A not specified Likely benign (Apr 25, 2023)2508151
20-388125-C-T not specified Uncertain significance (Sep 20, 2023)3182174
20-388144-C-T not specified Uncertain significance (Jul 08, 2022)2300130
20-388246-G-C not specified Uncertain significance (May 04, 2023)2562711
20-388248-G-A not specified Uncertain significance (Feb 13, 2024)3182175
20-391342-C-T not specified Uncertain significance (Oct 04, 2022)2355952
20-391359-C-T not specified Uncertain significance (Mar 07, 2024)3182176
20-391380-G-C not specified Uncertain significance (Oct 29, 2021)2216237
20-391387-A-G not specified Uncertain significance (Jun 30, 2022)2299654
20-391411-G-A not specified Uncertain significance (May 18, 2022)2404705
20-391414-C-T not specified Uncertain significance (Aug 26, 2022)2359646
20-391432-G-A Likely benign (Jan 01, 2024)3024848
20-391476-G-A not specified Uncertain significance (Jan 23, 2024)3182178
20-391485-C-T not specified Uncertain significance (Aug 17, 2022)2395058
20-391486-G-A not specified Uncertain significance (Nov 17, 2023)3182179
20-391555-G-A not specified Uncertain significance (Jul 28, 2021)3182180
20-396317-C-T not specified Uncertain significance (Jan 19, 2022)2272346
20-396326-C-T not specified Uncertain significance (Oct 04, 2022)2364653
20-396343-G-A not specified Uncertain significance (Oct 24, 2023)3182181
20-396363-G-A Benign (Dec 13, 2017)733898
20-396383-G-A not specified Uncertain significance (Sep 13, 2023)2623176

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TRIB3protein_codingprotein_codingENST00000217233 316943
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.16e-130.0032512556301821257450.000724
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1942382301.040.00001672224
Missense in Polyphen8290.1890.9092939
Synonymous0.1811021040.9770.00000736834
Loss of Function-1.281712.21.408.60e-7110

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002520.00252
Ashkenazi Jewish0.000.00
East Asian0.001630.00147
Finnish0.000.00
European (Non-Finnish)0.0003120.000308
Middle Eastern0.001630.00147
South Asian0.002420.00242
Other0.0009820.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Disrupts insulin signaling by binding directly to Akt kinases and blocking their activation. May bind directly to and mask the 'Thr-308' phosphorylation site in AKT1. Binds to ATF4 and inhibits its transcriptional activation activity. Interacts with the NF-kappa-B transactivator p65 RELA and inhibits its phosphorylation and thus its transcriptional activation activity. Interacts with MAPK kinases and regulates activation of MAP kinases. May play a role in programmed neuronal cell death but does not appear to affect non-neuronal cells. Does not display kinase activity. Inhibits the transcriptional activity of DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell death during ER stress. Can inhibit APOBEC3A editing of nuclear DNA. {ECO:0000269|PubMed:12736262, ECO:0000269|PubMed:15299019, ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:15781252, ECO:0000269|PubMed:22977230}.;
Pathway
Insulin resistance - Homo sapiens (human);Adipogenesis;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Photodynamic therapy-induced unfolded protein response;Insulin Signaling;Signal Transduction;VEGFA-VEGFR2 Pathway;Activation of AKT2;CD28 dependent PI3K/Akt signaling;CD28 co-stimulation;PI3K Cascade;Costimulation by the CD28 family;IRS-mediated signalling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Immune System;Adaptive Immune System;PIP3 activates AKT signaling;Negative regulation of the PI3K/AKT network;Signaling by VEGF;IRS-related events triggered by IGF1R;IGF1R signaling cascade;TNFalpha;Signaling by Receptor Tyrosine Kinases;Intracellular signaling by second messengers;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);VEGFR2 mediated vascular permeability (Consensus)

Recessive Scores

pRec
0.0920

Intolerance Scores

loftool
0.956
rvis_EVS
0.47
rvis_percentile_EVS
78.8

Haploinsufficiency Scores

pHI
0.120
hipred
N
hipred_score
0.398
ghis
0.383

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.979

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Trib3
Phenotype
cellular phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
trib3
Affected structure
determination of liver left/right asymmetry
Phenotype tag
abnormal
Phenotype quality
disrupted

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;protein phosphorylation;negative regulation of protein kinase activity;regulation of glucose transmembrane transport;regulation of lipid metabolic process;positive regulation of protein binding;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;cellular response to insulin stimulus;response to endoplasmic reticulum stress;regulation of MAP kinase activity;negative regulation of fat cell differentiation;negative regulation of fatty acid biosynthetic process;negative regulation of transcription, DNA-templated;positive regulation of ubiquitin-protein transferase activity;negative regulation of protein kinase B signaling;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
Cellular component
nucleus;cytosol;plasma membrane
Molecular function
transcription corepressor activity;protein kinase inhibitor activity;protein binding;ATP binding;kinase activity;protein kinase binding;mitogen-activated protein kinase kinase binding;ubiquitin protein ligase binding;ubiquitin-protein transferase regulator activity